SIFROL Side Effects

6870778-6 | Restless Legs Syndrome, Rib Fracture, Somnambulism
on Jul 01, 2010 Female patient from , weighting 158.7 lb, was diagnosed with restless legs syndrome, poor quality sleep and was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: restless legs syndrome, rib fracture, somnambulism. Sifrol dosage: Half Daily For One Week Then Once Daily. During the same period patient was treated with ANAFRANIL (10 Mg) (View Anafranil Review and Anafranil Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), NEBILOX (2.5 Mg) (View Nebilox Review and Nebilox Label ), L72 (60drops) (View L72 Review and L72 Label ).

6795764-6 | Micturition Disorder, Urinary Retention, Urinary Tract Infection
Patient was taking Sifrol (View Usage). Patient had the following side effects: micturition disorder, urinary retention, urinary tract infection (What is urinary tract infection?) on Jun 16, 2010 from Additional patient health information: Female patient , 55 years of age, was diagnosed with restless legs syndrome and. Sifrol dosage: 0.18 Mg.

6761919-X | Camptocormia, Posture Abnormal
Adverse event was reported on Jun 01, 2010 by a Female patient taking Sifrol (View Usage) (Dosage: Up-titrated To 3 Mg/day Over A 2-months Period) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: , 60 years of age, After Sifrol was administered, patient had the following side effects: camptocormia, posture abnormal. During the same period patient was treated with PERGOLIDE (View Pergolide Review and Pergolide Label ). Patient was hospitalized.

6760070-2 | Oesophageal Carcinoma
on May 31, 2010 Male patient from , 67 years of age, weighting 154.3 lb, was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal carcinoma. Sifrol dosage: . During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), TRAMADOL (View Tramadol Review and Tramadol Label ).


6727513-1 | Psychosexual Disorder
on May 05, 2010 Male patient from , 76 years of age, weighting 121.3 lb, was treated with Sifrol (View Usage). Patient had the following side effects: psychosexual disorder. Sifrol dosage: . During the same period patient was treated with SINEMET (50/200mg Carbidopa/levodopa Combi) (View Sinemet Review and Sinemet Label ), STALEVO 100 (100/25/200 Levodopa/carbidopa/entacapone Combi) (View Stalevo 100 Review and Stalevo 100 Label ), AMARYL (4 Mg) (View Amaryl Review and Amaryl Label ), GLUCOPHAGE (850 Mg) (View Glucophage Review and Glucophage Label ), NULYTELY (1 Anz) (View Nulytely Review and Nulytely Label ), LAXOBERON (15 Drops) (View Laxoberon Review and Laxoberon Label ), ACIDE FOLIQUE (5 Mg) (View Acide Folique Review and Acide Folique Label ).

6702106-0 | Hypersensitivity, Inflammation, Oedema Peripheral, Pruritus, Rash Pustular, Skin Haemorrhage
Patient was taking Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: hypersensitivity, inflammation, oedema peripheral, pruritus, rash pustular, skin haemorrhage on Apr 14, 2010 from Additional patient health information: Male patient , weighting 187.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Sifrol dosage: 1.05 Mg. During the same period patient was treated with LEVODOP NEURAX (100 Mg Levodopa / 25 Mg Carbidopa) (View Levodop-neurax Review and Levodop-neurax Label ), ASS 100 HEXAL (100 Mg) (View Ass 100 Hexal Review and Ass 100 Hexal Label ), BETAHISTIN STADA 6 (12 Mg) (View Betahistin Stada 6 Review and Betahistin Stada 6 Label ), EMESTAR PLUS 600/12,5 (1 Anz) (View Emestar Plus 600/12,5 Review and Emestar Plus 600/12,5 Label ), EUTHYROX 125 (125 Mcg) (View Euthyrox 125 Review and Euthyrox 125 Label ), LISODURA 10 (10 Mg) (View Lisodura 10 Review and Lisodura 10 Label ), MOXODURA O,3 (0.3 Mg) (View Moxodura O,3 Review and Moxodura O,3 Label ).

6636768-3 | Angioedema
Adverse event was reported on Mar 08, 2010 by a Female patient taking Sifrol (View Usage) (Dosage: ) was diagnosed with restless legs syndrome and. Location: , 58 years of age, Patient experienced the following unwanted or unexpected effects: angioedema. During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

6632251-X | Hepatic Enzyme Increased, Nausea, Renal Failure Acute
on Feb 25, 2010 Female patient from , 90 years of age, was diagnosed with restless legs syndrome, staphylococcal bacteraemia, muscle spasms, osteoarthritis (What is osteoarthritis?) and was treated with Sifrol (View Usage). Patient had the following side effects: hepatic enzyme increased, nausea (What is nausea?), renal failure acute. Sifrol dosage: 0.125 Mg. During the same period patient was treated with FLOXAPEN (8 G) (View Floxapen Review and Floxapen Label ), MYDOCALM (150 Mg) (View Mydocalm Review and Mydocalm Label ), DAFALGAN (3 G) (View Dafalgan Review and Dafalgan Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), APROVEL (150 Mg) (View Aprovel Review and Aprovel Label ), AMLODIPINE (5 Mg) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6597603-5 | Coma, Suicide Attempt
on Feb 15, 2010 Female patient from , 50 years of age, was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: coma, suicide attempt. Sifrol dosage: . During the same period patient was treated with ALMOGRAN (View Almogran Review and Almogran Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6583633-6 | Eosinophilic Pneumonia
Patient was taking Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia on Feb 03, 2010 from Additional patient health information: Male patient , weighting 158.7 lb, . Sifrol dosage: 4.5 Mg. Patient was hospitalized.

6577071-X | Agitation, Hallucination, Hypothyroidism, Osteoporotic Fracture, Suicide Attempt, Tremor
Adverse event was reported on Jan 28, 2010 by a Female patient taking Sifrol (View Usage) (Dosage: 3 Anz) was diagnosed with back pain (What is back pain?) and. Location: , weighting 108.2 lb, Patient had the following side effects: agitation, hallucination, hypothyroidism, osteoporotic fracture, suicide attempt, tremor. During the same period patient was treated with STALEVO 100 (800 Mg) (View Stalevo 100 Review and Stalevo 100 Label ), SINEMET (200mglp +100mg) (View Sinemet Review and Sinemet Label ), MORPHINE (View Morphine Review and Morphine Label ), PROZAC (20 Mg) (View Prozac Review and Prozac Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

6538296-2 | Hyperkinesia, Overdose, Restlessness, Suicide Attempt
on Jan 07, 2010 Female patient from , weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: hyperkinesia, overdose, restlessness, suicide attempt. Sifrol dosage: . During the same period patient was treated with COMTESS (20 Anz) (View Comtess Review and Comtess Label ), NACOM (30 Anz) (View Nacom Review and Nacom Label ), TARGIN (10 Anz) (View Targin Review and Targin Label ).

6451799-4 | Gallbladder Operation
on Nov 09, 2009 Female patient from , weighting 242.5 lb, was diagnosed with restless legs syndrome, hypertension, diabetes mellitus and was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: gallbladder operation. Sifrol dosage: 0.18 Mg. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ). Patient was hospitalized.

6446218-8 | Dementia With Lewy Bodies, Eye Movement Disorder, Hallucination, Hallucination, Visual
Patient was taking Sifrol (View Usage). Patient had the following side effects: dementia with lewy bodies, eye movement disorder, hallucination, hallucination, visual on Nov 10, 2009 from Additional patient health information: Male patient , 71 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Sifrol dosage: .

6443711-9 | Gallbladder Operation
Adverse event was reported on Nov 09, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: 0.18 Mg) was diagnosed with restless legs syndrome, hypertension, diabetes mellitus and. Location: , weighting 242.5 lb, After Sifrol was administered, patient had the following side effects: gallbladder operation. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ). Patient was hospitalized.

6441907-3 | Gallbladder Operation
on Nov 03, 2009 Female patient from , 68 years of age, weighting 242.5 lb, was diagnosed with restless legs syndrome, hypertension, diabetes mellitus and was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: gallbladder operation. Sifrol dosage: 0.088 Mg. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ). Patient was hospitalized.

6435116-1 | Abortion Induced
on Oct 28, 2009 Female patient from , 37 years of age, was diagnosed with extrapyramidal disorder, constipation (What is constipation?), bipolar disorder (What is bipolar disorder?), anxiety disorder, pain (What is pain?) and was treated with Sifrol (View Usage). Patient had the following side effects: abortion induced. Sifrol dosage: 0.125 Mg. During the same period patient was treated with LAXOBERON (View Laxoberon Review and Laxoberon Label ), DEPAKENE (View Depakene Review and Depakene Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), SEROQUEL (100 Mg) (View Seroquel Review and Seroquel Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), MEFENAMIC ACID (View Mefenamic Acid Review and Mefenamic Acid Label ).

6432936-4 | Dementia With Lewy Bodies, Eye Movement Disorder, Hallucination, Hallucination, Visual
Patient was taking Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: dementia with lewy bodies, eye movement disorder, hallucination, hallucination, visual on Oct 28, 2009 from Additional patient health information: Male patient , 71 years of age, . Sifrol dosage: .

6404355-8 | Asthenopia, Constipation, Insomnia, Visual Impairment
Adverse event was reported on Oct 12, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: 1.98 Mg) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: , weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: asthenopia, constipation (What is constipation?), insomnia, visual impairment. During the same period patient was treated with MANTADIX (100 Mg) (View Mantadix Review and Mantadix Label ), STALEVO 100 (125/200 Mg) (View Stalevo 100 Review and Stalevo 100 Label ), SINEMET (50 Mg) (View Sinemet Review and Sinemet Label ), SINEMET CR (50 Mg) (View Sinemet Cr Review and Sinemet Cr Label ).

6388624-6 | Condition Aggravated, Peripheral Coldness, Poor Peripheral Circulation, Raynaud's Phenomenon
on Sep 29, 2009 Female patient from , weighting 143.3 lb, was diagnosed with restless legs syndrome and was treated with Sifrol (View Usage). Patient had the following side effects: condition aggravated, peripheral coldness, poor peripheral circulation, raynaud's phenomenon. Sifrol dosage: 0.18 Mg.

6384958-X | Acoustic Neuroma
on Sep 25, 2009 Male patient from , weighting 174.2 lb, was diagnosed with restless legs syndrome and was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: acoustic neuroma (What is acoustic neuroma?). Sifrol dosage: . During the same period patient was treated with AMBROXOL (View Ambroxol Review and Ambroxol Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), SYMBICORT (400/12mcg) (View Symbicort Review and Symbicort Label ), LYRICA (View Lyrica Review and Lyrica Label ).

6376180-8 | Peripheral Coldness, Peripheral Vascular Disorder, Poor Peripheral Circulation
Patient was taking Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: peripheral coldness, peripheral vascular disorder, poor peripheral circulation on Sep 17, 2009 from Additional patient health information: Female patient , 60 years of age, was diagnosed with restless legs syndrome and. Sifrol dosage: 0.18 Mg.

6358355-7 | Cardiomyopathy, Chest Discomfort, Decreased Appetite, Neuroleptic Malignant Syndrome, Pyrexia
Adverse event was reported on Sep 09, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: 1.5 Mg) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: , 62 years of age, Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), chest discomfort, decreased appetite, neuroleptic malignant syndrome, pyrexia. During the same period patient was treated with SYMMETREL (300 Mg) (View Symmetrel Review and Symmetrel Label ), CARBIDOPA AND LEVODOPA (L-dopa 500 Mg) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ). Patient was hospitalized.

6341775-4 | Cardiomyopathy, Chest Discomfort, Decreased Appetite, Neuroleptic Malignant Syndrome, Pyrexia
on Aug 31, 2009 Female patient from , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), chest discomfort, decreased appetite, neuroleptic malignant syndrome, pyrexia. Sifrol dosage: 1.5 Mg. During the same period patient was treated with SYMMETREL (300 Mg) (View Symmetrel Review and Symmetrel Label ), CARBIDOPA AND LEVODOPA (L-dopa 500 Mg) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ). Patient was hospitalized.

6331693-X | Cardiomyopathy, Chest Discomfort, Decreased Appetite, Neuroleptic Malignant Syndrome, Pyrexia
on Aug 19, 2009 Female patient from , 62 years of age, was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?), chest discomfort, decreased appetite, neuroleptic malignant syndrome, pyrexia. Sifrol dosage: .

6302166-5 | Overdose, Somnolence, Suicide Attempt
Patient was taking Sifrol (View Usage). Patient had the following side effects: overdose, somnolence, suicide attempt on Aug 03, 2009 from Additional patient health information: Female patient , 78 years of age, . Sifrol dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), PK MERZ 100 (20 Anz) (View Pk Merz 100 Review and Pk Merz 100 Label ).

6264803-3 | Abortion Spontaneous
Adverse event was reported on Jul 06, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: 0.18 Mg) was diagnosed with restless legs syndrome and. Location: , 40 years of age, After Sifrol was administered, patient had the following side effects: abortion spontaneous.

6249961-9 | Bradycardia, Hypotension, Overdose, Suicide Attempt
on Jun 22, 2009 Male patient from , weighting 154.3 lb, was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, hypotension, overdose, suicide attempt. Sifrol dosage: 7.5 Tablets. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (5 X 20 Mg Tablets) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LEVOCOMP (5 Tablets 100 Mg Levodopa / 25 Mg Carbidopa) (View Levocomp Review and Levocomp Label ), LOCOL (5 Tablets) (View Locol Review and Locol Label ), MARCUMAR (2.5 Tablets) (View Marcumar Review and Marcumar Label ), METOPROLOL SUCCINATE (5 Tablets) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), MONOBETA (5 Tablets) (View Monobeta Review and Monobeta Label ), OMEPRAZOL (5 Tablets) (View Omeprazol Review and Omeprazol Label ), CLONAZEPAM (5 Tablets) (View Clonazepam Review and Clonazepam Label ).

6244742-4 | Abnormal Behaviour, Aggression, Condition Aggravated, Depression, Economic Problem, Pain In Extremity, Personality Change, Social Problem
on Jun 17, 2009 Male patient from , 42 years of age, weighting 209.4 lb, was diagnosed with restless legs syndrome and was treated with Sifrol (View Usage). Patient had the following side effects: abnormal behaviour, aggression, condition aggravated, depression (What is depression?), economic problem, pain in extremity, personality change, social problem. Sifrol dosage: 1/2-2. During the same period patient was treated with RESTEX (View Restex Review and Restex Label ).

6198836-2 | Atrial Fibrillation, Circulatory Collapse, Condition Aggravated, Heart Rate Increased, Loss Of Consciousness, Mobility Decreased, Shock
Patient was taking Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), circulatory collapse, condition aggravated, heart rate increased, loss of consciousness, mobility decreased, shock on May 14, 2009 from Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with parkinsonism and. Sifrol dosage: 2.8mg. Patient was hospitalized.

6193691-9 | Epilepsy, Myoclonic Epilepsy
Adverse event was reported on May 11, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: .088mg) was diagnosed with restless legs syndrome and. Location: , weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), myoclonic epilepsy. Patient was hospitalized.

6186444-9 | Bradycardia, Hypotension, Overdose, Suicide Attempt
on May 04, 2009 Male patient from , weighting 154.3 lb, was treated with Sifrol (View Usage). Patient had the following side effects: bradycardia, hypotension, overdose, suicide attempt. Sifrol dosage: 7.5 Tablets. During the same period patient was treated with CITALOPAM (5 X 20 Mg Tablets) (View Citalopam Review and Citalopam Label ), LEVOCOMP (5 Tablets 100 Mg Levodopa / 25 Mg Carbidopa) (View Levocomp Review and Levocomp Label ), LOCOL (5 Tablets) (View Locol Review and Locol Label ), MARCUMAR (2.5 Tablets) (View Marcumar Review and Marcumar Label ), METOPROLOL (5 Tablets) (View Metoprolol Review and Metoprolol Label ), MONOBETA (5 Tablets) (View Monobeta Review and Monobeta Label ), OMEPRAZOL (5 Tablets) (View Omeprazol Review and Omeprazol Label ), RIVOTRIL (5 Tablets) (View Rivotril Review and Rivotril Label ).

6166256-2 | Overdose, Suicide Attempt
on Apr 16, 2009 Female patient from , 50 years of age, was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: overdose, suicide attempt. Sifrol dosage: 30anz.

6144716-8 | Electrocardiogram St Segment Depression, Fatigue, Off Label Use, Sensation Of Heaviness, Sleep Disorder
Patient was taking Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram st segment depression, fatigue, off label use, sensation of heaviness, sleep disorder (What is sleep disorder?) on Mar 27, 2009 from Additional patient health information: Female patient , 60 years of age, was diagnosed with depression (What is depression?) and. Sifrol dosage: 1.14mg. During the same period patient was treated with CARMEN (20mg) (View Carmen Review and Carmen Label ), TAVOR (.5mg) (View Tavor Review and Tavor Label ), MAGNESIUM SULFATE (2 Bags) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), PAROXETINE HCL (20mg) (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

6123433-4 | Confusional State, Encephalopathy, Myoclonus
Adverse event was reported on Mar 06, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: 3.15mg) was diagnosed with parkinson's disease (What is parkinson's disease?), nausea (What is nausea?) and. Location: , 73 years of age, Patient had the following side effects: confusional state, encephalopathy, myoclonus. During the same period patient was treated with MODOPAR (187.5mg) (View Modopar Review and Modopar Label ), OTRASEL (1.25mg) (View Otrasel Review and Otrasel Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ). Patient was hospitalized.

6108497-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis
on Feb 25, 2009 Female patient from , 61 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?). Sifrol dosage: 2.1mg. Patient was hospitalized.

6108334-X | Cardiac Arrest
on Feb 18, 2009 Male patient from , 83 years of age, was diagnosed with restless legs syndrome and was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Sifrol dosage: .

6094525-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Sifrol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on Feb 18, 2009 from Additional patient health information: Female patient , 61 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Sifrol dosage: 2.1mg. Patient was hospitalized.

6082974-9 | Fall, Fracture, Hallucination, Multiple Fractures
Adverse event was reported on Feb 13, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: 1/2-0-1/2) was diagnosed with parkinson's disease (What is parkinson's disease?), depression (What is depression?) and. Location: , 76 years of age, After Sifrol was administered, patient had the following side effects: fall (What is fall?), fracture (What is fracture?), hallucination, multiple fractures. During the same period patient was treated with MADOPAR (200 Mg/50mg - Tablets, 3 X Daily) (View Madopar Review and Madopar Label ), CITALOPRAM HYDROBROMID (1-0-0) (View Citalopram Hydrobromid Review and Citalopram Hydrobromid Label ).

6080881-9 | Oedema Peripheral, Pneumonia, Pulmonary Oedema
on Feb 06, 2009 Female patient from , weighting 132.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, pneumonia (What is pneumonia?), pulmonary oedema. Sifrol dosage: 1.05mg. During the same period patient was treated with STALEVO 100 (450mg) (View Stalevo 100 Review and Stalevo 100 Label ), AMITRIPTYLINE HCL (25mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CITALOPRAM HYDROBROMIDE (40mg) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6078152-X | Oedema Peripheral, Pneumonia, Pulmonary Oedema
on Feb 09, 2009 Female patient from , weighting 132.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). Patient had the following side effects: oedema peripheral, pneumonia (What is pneumonia?), pulmonary oedema. Sifrol dosage: 1.05mg. During the same period patient was treated with STALEVO 100 (450mg) (View Stalevo 100 Review and Stalevo 100 Label ), AMITRIPTYLINE HCL (25mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CITALOPRAM HYDROBROMIDE (40mg) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6055946-8 | Dyskinesia
Patient was taking Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: dyskinesia on Jan 15, 2009 from Additional patient health information: Female patient , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Sifrol dosage: 1.05mg. During the same period patient was treated with PIROXICAM (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.

6055939-0 | Retinopathy
Adverse event was reported on Jan 15, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: .25mg) was diagnosed with restless legs syndrome, breast cancer in situ and. Location: , 52 years of age, Patient experienced the following unwanted or unexpected effects: retinopathy. During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ), ATACAND (View Atacand Review and Atacand Label ), PAROXETINE HCL (10mg) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), NEXIUM (As Necessary) (View Nexium Review and Nexium Label ), PADMED CIRCOSAN (View Padmed Circosan Review and Padmed Circosan Label ).

6055937-7 | Hypoalbuminaemia, Nephrotic Syndrome, Proteinuria
on Jan 15, 2009 Female patient from , 48 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). Patient had the following side effects: hypoalbuminaemia, nephrotic syndrome, proteinuria. Sifrol dosage: 3.15mg. During the same period patient was treated with MODOPAR (937.5mg) (View Modopar Review and Modopar Label ), LEVOTHYROX (50mcg) (View Levothyrox Review and Levothyrox Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ). Patient was hospitalized.

6045852-7 | Dysstasia, Eye Movement Disorder, Gait Disturbance, Sleep Disorder, Somnolence
on Jan 13, 2009 Female patient from , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: dysstasia, eye movement disorder, gait disturbance, sleep disorder (What is sleep disorder?), somnolence. Sifrol dosage: Refer To Narrative. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), MANTIDAN (View Mantidan Review and Mantidan Label ).

6042433-6 | Dyskinesia
Patient was taking Sifrol (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia on Jan 13, 2009 from Additional patient health information: Female patient , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Sifrol dosage: 1.05mg. During the same period patient was treated with PIROXICAM (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.

6037587-1 | Dysstasia, Eye Movement Disorder, Gait Disturbance, Sleep Disorder, Somnolence
Adverse event was reported on Jan 05, 2009 by a Female patient taking Sifrol (View Usage) (Dosage: Refer To Narrative) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: , 69 years of age, Patient had the following side effects: dysstasia, eye movement disorder, gait disturbance, sleep disorder (What is sleep disorder?), somnolence. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), MANTIDAN (View Mantidan Review and Mantidan Label ).

6033502-5 | Dyspnoea Exertional, Hyperphagia, Obsessive-compulsive Personality Disorder, Parkinson's Disease, Weight Increased
on Jan 06, 2009 Male patient from , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Sifrol (View Usage). After Sifrol was administered, patient had the following side effects: dyspnoea exertional, hyperphagia, obsessive-compulsive personality disorder, parkinson's disease (What is parkinson's disease?), weight increased. Sifrol dosage: 1.5mg. During the same period patient was treated with SINEMET (375mg) (View Sinemet Review and Sinemet Label ).

6029263-6 |
on Jan 05, 2009 Female patient from , weighting 149.9 lb, was diagnosed with progressive supranuclear palsy (What is progressive supranuclear palsy?) and was treated with Sifrol (View Usage). . Sifrol dosage: 4.5mg. During the same period patient was treated with CABASER (View Cabaser Review and Cabaser Label ), PERINDOPRIL ERBUMINE (2.5mg) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), EFEXOR SR (75mg) (View Efexor Sr Review and Efexor Sr Label ), SINEMET (100mg/25mg) (View Sinemet Review and Sinemet Label ).

6016762-6 | Abnormal Faeces, Dizziness, Headache, Movement Disorder, Muscle Spasms, Nausea, Pain In Extremity, Somnolence, Visual Acuity Reduced
Patient was taking Sifrol (View Usage). Patient had the following side effects: abnormal faeces, dizziness (What is dizziness?), headache (What is headache?), movement disorder (What is movement disorder?), muscle spasms, nausea (What is nausea?), pain in extremity, somnolence, visual acuity reduced on Dec 16, 2008 from Additional patient health information: Male patient , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Sifrol dosage: 1mg. During the same period patient was treated with DICETEL (View Dicetel Review and Dicetel Label ).